Selected research
Industry Research
Large Molecule Bioanalytical Testing Services Industry Research Report 2026
Market perspective
The global Large Molecule Bioanalytical Testing Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Large Molecule Bioanalytical Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Large Molecule Bioanalytical Testing Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Large Molecule Bioanalytical Testing Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Large Molecule Bioanalytical Testing Services include LabCorp (Covance Inc.), IQVIA Inc., Thermo Fisher Scientific, Charles River Laboratories, Syneos Health, ICON plc, PPD Inc. (Thermo Fisher), SGS S.A. and Intertek Group plc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Large Molecule Bioanalytical Testing Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Large Molecule Bioanalytical Testing Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Large Molecule Bioanalytical Testing Services Market by Company
LabCorp (Covance Inc.)
IQVIA Inc.
Thermo Fisher Scientific
Charles River Laboratories
Syneos Health
ICON plc
PPD Inc. (Thermo Fisher)
SGS S.A.
Intertek Group plc
Eurofins Scientific
WuXi AppTec
Medpace Holdings, Inc.
Parexel International
Q2 Solutions (IQVIA)
BioAgilytix
Pace Analytical Services
Toxikon Corporation
Boehringer Ingelheim
Fujifilm Diosynth Biotechnologies
Large Molecule Bioanalytical Testing Services Segment by Type
Fee-for-Service (FFS)
Full-Service Outsourcing
Functional Service Provider (FSP)
Large Molecule Bioanalytical Testing Services Segment by Application
Full-Service CRO
Specialized Bioanalytical Lab
CDMO with Testing Capabilities
Academic Core Facility
Others
Large Molecule Bioanalytical Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Molecule Bioanalytical Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Large Molecule Bioanalytical Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Molecule Bioanalytical Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Large Molecule Bioanalytical Testing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fee-for-Service (FFS)
- Full-Service Outsourcing
- Functional Service Provider (FSP)
Applications
- Full-Service CRO
- Specialized Bioanalytical Lab
- CDMO with Testing Capabilities
- Academic Core Facility
- Others
Companies covered
- LabCorp (Covance Inc.)
- IQVIA Inc.
- Thermo Fisher Scientific
- Charles River Laboratories
- Syneos Health
- ICON plc
- PPD Inc. (Thermo Fisher)
- SGS S.A.
- Intertek Group plc
- Eurofins Scientific
- WuXi AppTec
- Medpace Holdings, Inc.
- Parexel International
- Q2 Solutions (IQVIA)
- BioAgilytix
- Pace Analytical Services
- Toxikon Corporation
- Boehringer Ingelheim
- Fujifilm Diosynth Biotechnologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Large Molecule Bioanalytical Testing Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Fee-for-Service (FFS)
- 2.2.3 Full-Service Outsourcing
- 2.2.4 Functional Service Provider (FSP)
- 2.3 Large Molecule Bioanalytical Testing Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Full-Service CRO
- 2.3.3 Specialized Bioanalytical Lab
- 2.3.4 CDMO with Testing Capabilities
- 2.3.5 Academic Core Facility
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Large Molecule Bioanalytical Testing Services Breakdown Data by Type
- 3.1 Global Large Molecule Bioanalytical Testing Services Historic Market Size by Type (2021-2026)
- 3.2 Global Large Molecule Bioanalytical Testing Services Forecasted Market Size by Type (2027-2032)
4 Large Molecule Bioanalytical Testing Services Breakdown Data by Application
- 4.1 Global Large Molecule Bioanalytical Testing Services Historic Market Size by Application (2021-2026)
- 4.2 Global Large Molecule Bioanalytical Testing Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Large Molecule Bioanalytical Testing Services Market Perspective (2021-2032)
- 5.2 Global Large Molecule Bioanalytical Testing Services Growth Trends by Region
- 5.2.1 Global Large Molecule Bioanalytical Testing Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Large Molecule Bioanalytical Testing Services Historic Market Size by Region (2021-2026)
- 5.2.3 Large Molecule Bioanalytical Testing Services Forecasted Market Size by Region (2027-2032)
- 5.3 Large Molecule Bioanalytical Testing Services Market Dynamics
- 5.3.1 Large Molecule Bioanalytical Testing Services Industry Trends
- 5.3.2 Large Molecule Bioanalytical Testing Services Market Drivers
- 5.3.3 Large Molecule Bioanalytical Testing Services Market Challenges
- 5.3.4 Large Molecule Bioanalytical Testing Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Large Molecule Bioanalytical Testing Services Players by Revenue
- 6.1.1 Global Top Large Molecule Bioanalytical Testing Services Players by Revenue (2021-2026)
- 6.1.2 Global Large Molecule Bioanalytical Testing Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Large Molecule Bioanalytical Testing Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Large Molecule Bioanalytical Testing Services Head Office and Area Served
- 6.4 Global Large Molecule Bioanalytical Testing Services Players, Product Type & Application
- 6.5 Global Large Molecule Bioanalytical Testing Services Manufacturers Established Date
- 6.6 Global Large Molecule Bioanalytical Testing Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Large Molecule Bioanalytical Testing Services Market Size (2021-2032)
- 7.2 North America Large Molecule Bioanalytical Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Large Molecule Bioanalytical Testing Services Market Size by Country (2021-2026)
- 7.4 North America Large Molecule Bioanalytical Testing Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Large Molecule Bioanalytical Testing Services Market Size (2021-2032)
- 8.2 Europe Large Molecule Bioanalytical Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Large Molecule Bioanalytical Testing Services Market Size by Country (2021-2026)
- 8.4 Europe Large Molecule Bioanalytical Testing Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Large Molecule Bioanalytical Testing Services Market Size (2021-2032)
- 9.2 Asia-Pacific Large Molecule Bioanalytical Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Large Molecule Bioanalytical Testing Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Large Molecule Bioanalytical Testing Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Large Molecule Bioanalytical Testing Services Market Size (2021-2032)
- 10.2 South America Large Molecule Bioanalytical Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Large Molecule Bioanalytical Testing Services Market Size by Country (2021-2026)
- 10.4 South America Large Molecule Bioanalytical Testing Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Large Molecule Bioanalytical Testing Services Market Size (2021-2032)
- 11.2 Middle East & Africa Large Molecule Bioanalytical Testing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Large Molecule Bioanalytical Testing Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Large Molecule Bioanalytical Testing Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 LabCorp (Covance Inc.)
- 12.1.1 LabCorp (Covance Inc.) Company Information
- 12.1.2 LabCorp (Covance Inc.) Business Overview
- 12.1.3 LabCorp (Covance Inc.) Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.1.4 LabCorp (Covance Inc.) Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.1.5 LabCorp (Covance Inc.) Recent Developments
- 12.2 IQVIA Inc.
- 12.2.1 IQVIA Inc. Company Information
- 12.2.2 IQVIA Inc. Business Overview
- 12.2.3 IQVIA Inc. Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.2.4 IQVIA Inc. Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.2.5 IQVIA Inc. Recent Developments
- 12.3 Thermo Fisher Scientific
- 12.3.1 Thermo Fisher Scientific Company Information
- 12.3.2 Thermo Fisher Scientific Business Overview
- 12.3.3 Thermo Fisher Scientific Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.3.4 Thermo Fisher Scientific Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.3.5 Thermo Fisher Scientific Recent Developments
- 12.4 Charles River Laboratories
- 12.4.1 Charles River Laboratories Company Information
- 12.4.2 Charles River Laboratories Business Overview
- 12.4.3 Charles River Laboratories Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.4.4 Charles River Laboratories Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.4.5 Charles River Laboratories Recent Developments
- 12.5 Syneos Health
- 12.5.1 Syneos Health Company Information
- 12.5.2 Syneos Health Business Overview
- 12.5.3 Syneos Health Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.5.4 Syneos Health Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.5.5 Syneos Health Recent Developments
- 12.6 ICON plc
- 12.6.1 ICON plc Company Information
- 12.6.2 ICON plc Business Overview
- 12.6.3 ICON plc Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.6.4 ICON plc Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.6.5 ICON plc Recent Developments
- 12.7 PPD Inc. (Thermo Fisher)
- 12.7.1 PPD Inc. (Thermo Fisher) Company Information
- 12.7.2 PPD Inc. (Thermo Fisher) Business Overview
- 12.7.3 PPD Inc. (Thermo Fisher) Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.7.4 PPD Inc. (Thermo Fisher) Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.7.5 PPD Inc. (Thermo Fisher) Recent Developments
- 12.8 SGS S.A.
- 12.8.1 SGS S.A. Company Information
- 12.8.2 SGS S.A. Business Overview
- 12.8.3 SGS S.A. Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.8.4 SGS S.A. Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.8.5 SGS S.A. Recent Developments
- 12.9 Intertek Group plc
- 12.9.1 Intertek Group plc Company Information
- 12.9.2 Intertek Group plc Business Overview
- 12.9.3 Intertek Group plc Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.9.4 Intertek Group plc Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.9.5 Intertek Group plc Recent Developments
- 12.10 Eurofins Scientific
- 12.10.1 Eurofins Scientific Company Information
- 12.10.2 Eurofins Scientific Business Overview
- 12.10.3 Eurofins Scientific Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.10.4 Eurofins Scientific Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.10.5 Eurofins Scientific Recent Developments
- 12.11 WuXi AppTec
- 12.11.1 WuXi AppTec Company Information
- 12.11.2 WuXi AppTec Business Overview
- 12.11.3 WuXi AppTec Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.11.4 WuXi AppTec Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.11.5 WuXi AppTec Recent Developments
- 12.12 Medpace Holdings, Inc.
- 12.12.1 Medpace Holdings, Inc. Company Information
- 12.12.2 Medpace Holdings, Inc. Business Overview
- 12.12.3 Medpace Holdings, Inc. Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.12.4 Medpace Holdings, Inc. Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.12.5 Medpace Holdings, Inc. Recent Developments
- 12.13 Parexel International
- 12.13.1 Parexel International Company Information
- 12.13.2 Parexel International Business Overview
- 12.13.3 Parexel International Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.13.4 Parexel International Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.13.5 Parexel International Recent Developments
- 12.14 Q2 Solutions (IQVIA)
- 12.14.1 Q2 Solutions (IQVIA) Company Information
- 12.14.2 Q2 Solutions (IQVIA) Business Overview
- 12.14.3 Q2 Solutions (IQVIA) Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.14.4 Q2 Solutions (IQVIA) Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.14.5 Q2 Solutions (IQVIA) Recent Developments
- 12.15 BioAgilytix
- 12.15.1 BioAgilytix Company Information
- 12.15.2 BioAgilytix Business Overview
- 12.15.3 BioAgilytix Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.15.4 BioAgilytix Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.15.5 BioAgilytix Recent Developments
- 12.16 Pace Analytical Services
- 12.16.1 Pace Analytical Services Company Information
- 12.16.2 Pace Analytical Services Business Overview
- 12.16.3 Pace Analytical Services Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.16.4 Pace Analytical Services Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.16.5 Pace Analytical Services Recent Developments
- 12.17 Toxikon Corporation
- 12.17.1 Toxikon Corporation Company Information
- 12.17.2 Toxikon Corporation Business Overview
- 12.17.3 Toxikon Corporation Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.17.4 Toxikon Corporation Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.17.5 Toxikon Corporation Recent Developments
- 12.18 Boehringer Ingelheim
- 12.18.1 Boehringer Ingelheim Company Information
- 12.18.2 Boehringer Ingelheim Business Overview
- 12.18.3 Boehringer Ingelheim Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.18.4 Boehringer Ingelheim Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.18.5 Boehringer Ingelheim Recent Developments
- 12.19 Fujifilm Diosynth Biotechnologies
- 12.19.1 Fujifilm Diosynth Biotechnologies Company Information
- 12.19.2 Fujifilm Diosynth Biotechnologies Business Overview
- 12.19.3 Fujifilm Diosynth Biotechnologies Revenue in Large Molecule Bioanalytical Testing Services Business (2021-2026)
- 12.19.4 Fujifilm Diosynth Biotechnologies Large Molecule Bioanalytical Testing Services Product Portfolio
- 12.19.5 Fujifilm Diosynth Biotechnologies Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst